| Tretinoin | Approved Investigational Nutraceutical | SURF6 | 6838 |
downregulated | Tretinoin results in decreased expression of SURF6 mRNA | 9q34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SVEP1 | 79987 |
upregulated | Tretinoin results in increased expression of SVEP1 mRNA | 9q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SVIP | 258010 |
upregulated | Tretinoin results in increased expression of SVIP mRNA | 11p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SVOP | 55530 |
upregulated | Tretinoin results in increased expression of SVOP mRNA | 12q24.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SWAP70 | 23075 |
downregulated | Tretinoin results in decreased expression of SWAP70 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | SWI5 | 375757 |
upregulated | Tretinoin results in increased expression of SWI5 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SYBU | 55638 |
downregulated | Tretinoin results in decreased expression of SYBU mRNA | 8q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SYK | 6850 |
downregulated | Tretinoin results in decreased expression of SYK mRNA | 9q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNCRIP | 10492 |
downregulated | Tretinoin results in decreased expression of SYNCRIP mRNA | 6q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNE1 | 23345 |
upregulated | Tretinoin results in increased expression of SYNE1 mRNA | 6q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNE3 | 161176 |
downregulated | Tretinoin results in decreased expression of SYNE3 mRNA | 14q32.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNGR2 | 9144 |
downregulated | Tretinoin results in decreased expression of SYNGR2 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNGR3 | 9143 |
downregulated | Tretinoin results in decreased expression of SYNGR3 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNJ2 | 8871 |
upregulated | Tretinoin results in increased expression of SYNJ2 mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNM | 23336 |
downregulated | Tretinoin results in decreased expression of SYNM mRNA | 15q26.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYNPO2 | 171024 |
upregulated | Tretinoin results in increased expression of SYNPO2 mRNA | 4q26 | |
| Tretinoin | Approved Investigational Nutraceutical | SYP | 6855 |
upregulated | Tretinoin results in increased expression of SYP mRNA | Xp11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT1 | 6857 |
downregulated | Tretinoin results in decreased expression of SYT1 mRNA | 12q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT11 | 23208 |
downregulated | Tretinoin results in decreased expression of SYT11 mRNA | 1q22 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT13 | 57586 |
downregulated | Tretinoin results in decreased expression of SYT13 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT15 | 83849 |
upregulated | Tretinoin results in increased expression of SYT15 mRNA | 10q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT17 | 51760 |
upregulated | Tretinoin results in increased expression of SYT17 mRNA | 16p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT3 | 84258 |
downregulated | Tretinoin results in decreased expression of SYT3 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SYT5 | 6861 |
upregulated | Tretinoin results in increased expression of SYT5 mRNA | 19q13.42 | |
| Tretinoin | Approved Investigational Nutraceutical | SYTL1 | 84958 |
downregulated | Tretinoin results in decreased expression of SYTL1 mRNA | 1p36.11 | |